Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 boceprevir study in chronic hepatitis C genotype 1 patients who failed prior peginterferon/ribavirin treatment
2007-005151-42Phase 3Completed
- Sponsor
- Schering AG
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of boceprevir in hepatitis C virus infection, sponsored by Schering AG. Started Jun 2008; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2007-005151-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005151-42.